PRORota Clinical Trial Launched to Address Childhood Diarrhoeal Diseases and Antimicrobial Resistance

TLDR

• The PRORota clinical trial has been launched in Dar es Salaam, Tanzania, to address childhood diarrhoeal diseases and antimicrobial resistance.
• The trial involves researchers and health institutions from Tanzania, Malawi, Ivory Coast, and Norway.
• The Deputy Permanent Secretary in the Prime Minister’s Office for Health, Professor Tumaini Nagu, emphasized the importance of this research for Tanzania and Africa.
• Tanzania has reduced under-five mortality from 65 to 43 deaths per 1,000 live births, highlighting the need for ongoing research to combat preventable diseases.
• Diarrhoea is a significant cause of childhood illness and death, particularly among vulnerable children, and the trial aims to explore the role of probiotics in enhancing rotavirus vaccination effectiveness.